ABVX

AbivaxA

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Curated Events

Active

Recent Headlines

New

Curated events

Materiality

79.25

Source

External coverage

Decided

2026-06-02

Biotech takeover target Abivax sinks over 30% after bowel disease drug trial update

Abivax SA ADR fell sharply after fresh data on its lead bowel-disease asset, signaling a near-term negative read-through for the issuer and a watch item for trial credibility/next-step visibility.

View event details

Sentiment decomposition

+100.0

30-day score

Company-55%

Macro-30%

Pulse-15%

The 30-day sentiment score is a decayed blend of Company, Macro, and Pulse components.

Recent headlines

No supplemental ticker headlines stored yet

We are still collecting relevant articles for ABVX. Curated events highlight the most material developments impacting this ticker right now.

Check curated events Open full news archive

As of 2026-06-02 • Updated scheduledSource: News desk